EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review

Dana Tasabehji iD, Sanaz Saleh iD, Mohamad Mokadem iD

Journal of Clinical Medicine · 06.06.2025 · 14 (12) · 4012

DOI: 10.3390/jcm14124012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.06.2025. Verfasst von Dana Tasabehji und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, US department to Veterans affairs, US Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review examines the effectiveness of various surgical and endoscopic bariatric interventions in improving several components of metabolic dysfunction-associated steatotic liver disease (MASLD). Roux-en-Y gastric bypass (RYGB) consistently showed substantial long-term reductions in liver fat, inflammation, and fibrosis, achieving resolution of steatosis in up to 95% of cases. Vertical sleeve gastrectomy (VSG) provided comparable hepatic benefits, significantly reducing liver fibrosis and steatosis in approximately 60% of patients. Adjustable gastric banding (AGB) demonstrated meaningful though comparatively modest hepatic improvements, with steatosis resolution in about 42% of patients. More aggressive procedures like biliopancreatic diversion with duodenal switch (BPD-DS) showed profound metabolic effects, though with increased nutritional risk. Endoscopic therapies, including intragastric balloon (IGB) and endoscopic sleeve gastroplasty (ESG), offered notable short- to medium-term hepatic improvements, significantly reducing steatosis and fibrosis markers. Newer therapies like duodenal mucosal resurfacing (DMR) and the duodenal-jejunal bypass liner showed promising preliminary results, warranting further investigation. Overall, surgical interventions remain superior for sustained liver health improvements, while endoscopic therapies present viable alternatives for patients requiring less invasive interventions.

Schlagwörter

Stichwörter der Autor:innen

bariatric surgeryendoscopic bariatric and metabolic therapiesmetabolic dysfunction-associated steatohepatitis (MASH)metabolic dysfunction-associated steatotic liver disease (MASLD)obesity

Autor:innen und Institutionen

  • Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
  • Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, IA 52242, USA.
  • Obesity Research & Education Initiative, University of Iowa, Iowa City, IA 52242, USA.
  • Iowa City VA Health Care System, Iowa City, IA 52246, USA.

ORCID-Profile: Dana Tasabehji, Sanaz Saleh, Mohamad Mokadem

Förderung

  • BLRD VA
  • US department to Veterans affairs
  • US Department of Veterans Affairs
  • VA Merit Review Program
  • Department Internal Medicine at University of Iowa Carver College of Medicine
  • University of Iowa Fraternal Order of Eagles Diabetes Research Center

Zitieren

APA

Tasabehji, D., Saleh, S., & Mokadem, M. (2025). Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. Journal of Clinical Medicine, 14(12), 4012. https://doi.org/10.3390/jcm14124012

Vancouver

Tasabehji D, Saleh S, Mokadem M. Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. Journal of Clinical Medicine. 2025;14(12):4012. doi:10.3390/jcm14124012

BibTeX
@article{Tasabehji2025,
  author = {Tasabehji, Dana and Saleh, Sanaz and Mokadem, Mohamad},
  title = {Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {4012},
  doi = {10.3390/jcm14124012}
}
Kostenlos starten →